FIELD: organic chemistry, medicine, biochemistry, pharmacy.
SUBSTANCE: invention describes derivatives of imidazolidine-2,4-dione of the formula (I)
or its pharmaceutically acceptable salt wherein X is chosen from NR1; Y1 and Y2 represent oxygen atom (O); z is chosen from O or sulfur atom (S); A is chosen from a direct bond and (C1-C6)-alkyl; R1 is chosen from hydrogen atom (H) and (C1-C3)-alkyl; R2 is chosen from H, alkyl, cycloalkyl, aryl, heteroaryl, arylalkyl and heteroarylalkyl; R3 and R4 are chosen from H and (C1-C3)-alkyl; R2 can be substituted with one or more groups chosen from alkyl, halogen atom, hydroxy- and alkoxy-group; R2 and R3 can be joined to form a ring comprising up to 7 ring atoms; R5 represents bicyclic or tricyclic group comprising two or three ring structures wherein each comprises up to 6 ring atoms chosen independently from aryl or heteroaryl and wherein each ring structure can be substituted independently with one or more substitutes chosen independently from halogen atom, hydroxy-group, alkyl, alkoxy-group, halogenalkyl, halogenalkoxy-, amino-, N-alkylamino-, N,N-dialkylamino-, cyano-group and alkylsulfonyl, and each ring structure is joined with the next ring structure by a direct bond or through -O- or condensed with the next ring structure. Also, invention describes a pharmaceutical composition useful in inhibition of activity of metalloproteinases and using proposed compounds in preparing a drug. Derivatives of imidazolidine-2,4-dione are useful as inhibitors of metalloproteinases being especially as inhibitors of MMP12.
EFFECT: valuable medicinal and biochemical properties of compounds and pharmaceutical composition.
9 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2288228C2 |
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2002 |
|
RU2293730C2 |
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2002 |
|
RU2293729C2 |
NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES | 2005 |
|
RU2386629C2 |
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
BIPHENYLOXYACETIC ACID DERIVATIVES, USE THEREOF IN PREPARING MEDICINAL AGENT AND INTERMEDIATE COMPOUNDS | 2006 |
|
RU2424229C2 |
N-HYDROXYFORMAMIDE COMPOUNDS AS METALLOPROTEINASE INHIBITORS | 2004 |
|
RU2351595C2 |
INHIBITORS OF MATRIX METALLOPROTEINASES | 2004 |
|
RU2370488C2 |
PIPERIDINE- AND PIPERAZINE-SUBSTITUTED N-HYDROXYFORMAMIDES AS INHIBITORS OF METALLOPROTEINASES | 2001 |
|
RU2283306C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
Authors
Dates
2006-10-20—Published
2002-03-13—Filed